Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Pantoprazole on Duodenal Microbiome
NCT03545243Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Apr 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pantoprazole in functional dyspepsia (FD) (3 arms), sponsored by UZ Leuven. Primary endpoint: Change in microbiota composition at 4 weeks. Started Apr 2018; status: completed.
02
Drugs
pantoprazole
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT03545243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03545243.